Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             94 results found
no title author magazine year volume issue page(s) type
1 Acknowledgements
19 S4 p. iv4-iv5
article
2 aggressive lymphoma
19 S4 p. iv141-iv152
article
3 aggressive lymphoma
19 S4 p. iv216-iv222
article
4 amgen
19 S4 p. iv257-iv258
article
5 Amyloidosis: is a cure possible? Merlini, G.

19 S4 p. iv63-iv66
article
6 author index
19 S4 p. iv277-iv291
article
7 Autoimmune disorders and lymphoma Caligaris-Cappio, F.

19 S4 p. iv31-iv34
article
8 Bayer Schering Pharma
19 S4 p. iv276
article
9 bayer schering pharma
19 S4 p. iv270
article
10 Bing Center for Waldenström's macroglobulinemia update on plasma cell disorders
19 S4 p. iv267-iv269
article
11 biogen idec oncology
19 S4 p. iv264
article
12 Burkitt lymphoma versus diffuse large B-cell lymphoma Rosenwald, A.

19 S4 p. iv67-iv69
article
13 celgene
19 S4 p. iv271-iv272
article
14 celgene
19 S4 p. iv254
article
15 cephalon oncology
19 S4 p. iv255-iv256
article
16 CLL
19 S4 p. iv204-iv206
article
17 CLL
19 S4 p. iv192-iv196
article
18 Conference Schedule
19 S4 p. iv9-iv29
article
19 controversy I: do we need radiotherapy in early HL?
19 S4 p. iv82
article
20 controversy II: has PET changed the approach to lymphoma patients?
19 S4 p. iv122
article
21 Current treatment standards and future strategies in mantle cell lymphoma Dreyling, M.

19 S4 p. iv41-iv44
article
22 Editorial Board
19 S4 p. i, iii
article
23 epidemiology
19 S4 p. iv197-iv198
article
24 extranodal lymphoma
19 S4 p. iv223-iv229
article
25 extranodal lymphoma
19 S4 p. iv186-iv191
article
26 Extranodal lymphoma: a reappraisal Zucca, E.

19 S4 p. iv77-iv80
article
27 f. hoffmann la roche ltd giving your patients the best chance of cure
19 S4 p. iv261-iv263
article
28 “focus on…” session: CLL
19 S4 p. iv89-iv90
article
29 “focus on…” session: lymphoma biology
19 S4 p. iv125-iv126
article
30 “focus on…” session: new treatments modalities
19 S4 p. iv115-iv116
article
31 “focus on….” session: PET
19 S4 p. iv123-iv124
article
32 “focus on…” session: primary mediastinal and other extranodal lymphoma
19 S4 p. iv95-iv96
article
33 “focus on…” session: profiling and prognosis
19 S4 p. iv93-iv94
article
34 “focus on…” session: radioimmunotherapy
19 S4 p. iv87-iv88
article
35 “focus on…” session: T-cell
19 S4 p. iv113-iv114
article
36 “focus on…” session: transformation
19 S4 p. iv111-iv112
article
37 “focus on…” session: transplantation
19 S4 p. iv91-iv92
article
38 Genentech BioOncology
19 S4 p. iv273-iv274
article
39 glaxosmithkline
19 S4 p. iv259-iv260
article
40 Hodgkin lymphoma
19 S4 p. iv233-iv237
article
41 Hodgkin's lymphoma
19 S4 p. iv133-iv137
article
42 imaging
19 S4 p. iv249-iv251
article
43 indolent lymphoma
19 S4 p. iv176-iv185
article
44 Indolent NHL
19 S4 p. iv207-iv211
article
45 key note lectures
19 S4 p. iv81
article
46 lymphoma biology
19 S4 p. iv199-iv203
article
47 lymphoma biology
19 S4 p. iv166-iv170
article
48 Maintenance treatment in multiple myeloma Harousseau, J.L.

19 S4 p. iv54-iv55
article
49 mantle cell lymphoma
19 S4 p. iv172-iv175
article
50 mantle cell lymphoma
19 S4 p. iv212-iv215
article
51 MicroRNAs and lymphomas
19 S4 p. iv39-iv40
article
52 Millennium Pharmaceuticals Ortho Biotech, a division of Janssen-Cilag emerging therapies for relapsed and refractory lymphoid neoplasms
19 S4 p. iv275
article
53 miscellaneous
19 S4 p. iv252-iv253
article
54 multiple myeloma
19 S4 p. iv171
article
55 multiple myeloma/WM
19 S4 p. iv238
article
56 mundipharma
19 S4 p. iv265
article
57 New monoclonal antibodies for non-Hodgkin's lymphoma Leonard, J.P.

19 S4 p. iv60-iv62
article
58 New response criteria for lymphomas in clinical trials Cheson, B.D.

19 S4 p. iv35-iv38
article
59 New targets for lymphoma treatment Johnson, P.W.M.

19 S4 p. iv56-iv59
article
60 new treatment modalities
19 S4 p. iv243
article
61 new treatment modalities
19 S4 p. iv158-iv163
article
62 Non-MALT marginal zone lymphomas Thieblemont, C.

19 S4 p. iv70-iv73
article
63 pediatric lymphoma
19 S4 p. iv138-iv140
article
64 pediatrics
19 S4 p. iv248
article
65 poster session II, Friday 6 June (Marquee Parlo Ciani) pathology
19 S4 p. iv164-iv165
article
66 poster session I Thursday 5 June (Marquee Parco Ciani) epidemiology
19 S4 p. iv131-iv132
article
67 Prognostic factors in chronic lymphocytic leukemia Hallek, M.

19 S4 p. iv51-iv53
article
68 Radiotherapy in non-Hodgkin lymphomas Gospodarowicz, M.

19 S4 p. iv47-iv50
article
69 sanofi aventis
19 S4 p. iv266
article
70 Satellite Symposia Schedule
19 S4 p. iv8
article
71 session 14 – biological treatments
19 S4 p. iv129-iv130
article
72 session 3 – biology and novel rational therapeutic targets in DLBCL
19 S4 p. iv97-iv98
article
73 session 4 – diffuse large B-cell lymphoma
19 S4 p. iv99-iv100
article
74 session 6 – extranodal lymphoma
19 S4 p. iv103-iv104
article
75 session 5 – follicular lymphoma/CLL
19 S4 p. iv101-iv102
article
76 session 12 – hodgkin's lymphoma
19 S4 p. iv120-iv121
article
77 session 2 – mantle cell lymphoma
19 S4 p. iv85-iv86
article
78 session 9 – micro-RNA in lymphoid malignancies
19 S4 p. iv117
article
79 session 13 – new drugs
19 S4 p. iv127-iv128
article
80 session 7 – pathology and clinical/pathological correlations
19 S4 p. iv105-iv107
article
81 session 8 – pediatric lymphoma
19 S4 p. iv108-iv110
article
82 session 10 – review lectures
19 S4 p. iv118
article
83 session 11 – special topic: classifying lymphoma
19 S4 p. iv119
article
84 session 1 – 50th anniversary of Burkitt lymphoma
19 S4 p. iv83-iv84
article
85 subject index
19 S4 p. iv292-iv296
article
86 summary of Conference Schedule
19 S4 p. iv6-iv7
article
87 Table of Contents
19 S4 p. v
article
88 T-cell lymphoma
19 S4 p. iv153-iv157
article
89 T-cell lymphoma
19 S4 p. iv230-iv232
article
90 Title Page
19 S4 p. ii
article
91 transplantation
19 S4 p. iv239-iv242
article
92 Treatment of lymphocyte-predominant Hodgkin lymphoma Engert, A.

19 S4 p. iv45-iv46
article
93 treatment toxicity
19 S4 p. iv244-iv247
article
94 Update on T-cell lymphoma Vose, J.M.

19 S4 p. iv74-iv76
article
                             94 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands